Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang Yi

Showing results (601-610 of 607) with videos related to

Pageof 61
Sort By:
You have reached the last page of results.This site can display upto 607 results.
Eclinicalmedicine|July 18, 2022
ENERGI-F703 gel, as a new topical treatment for diabetic foot and leg ulcers: A multicenter, randomized, double-blind, phase II trialJui-Yung Yang, Cha-Chun Chen, Shun-Cheng Chang, et al.
Heart Rhythm|July 24, 2025
Predictive value of sudden cardiac death risk stratification for outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathyZhuo-Hang Du, Wei Wang, Xin Zhao, et al.
The Journal of Clinical Investigation|August 1, 2022
IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptomsBe-Sheng Kuo, Chao-Hung Li, Jiun-Bo Chen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 8, 2025
Ablation characteristics associated with steam pops in ablation index-guided radiofrequency ablation of atrial fibrillationXue-Si Wang, Ze-Yang Wu, Qi Wu, et al.
American Heart Journal|February 22, 2023
Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial designXiao-Xia Liu, Qiang Liu, Yi-Wei Lai, et al.
Emerging Microbes & Infections|October 26, 2022
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.
The Journal of Clinical Investigation|March 22, 2022
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variantsChang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, et al.
Pageof 61

Showing results (601-610 of 607) with videos related to

Sort By:
Pageof 61
You have reached the last page of results.This site can display upto 607 results.
Eclinicalmedicine|July 18, 2022
ENERGI-F703 gel, as a new topical treatment for diabetic foot and leg ulcers: A multicenter, randomized, double-blind, phase II trialJui-Yung Yang, Cha-Chun Chen, Shun-Cheng Chang, et al.
Heart Rhythm|July 24, 2025
Predictive value of sudden cardiac death risk stratification for outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathyZhuo-Hang Du, Wei Wang, Xin Zhao, et al.
The Journal of Clinical Investigation|August 1, 2022
IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptomsBe-Sheng Kuo, Chao-Hung Li, Jiun-Bo Chen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 8, 2025
Ablation characteristics associated with steam pops in ablation index-guided radiofrequency ablation of atrial fibrillationXue-Si Wang, Ze-Yang Wu, Qi Wu, et al.
American Heart Journal|February 22, 2023
Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial designXiao-Xia Liu, Qiang Liu, Yi-Wei Lai, et al.
Emerging Microbes & Infections|October 26, 2022
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.
The Journal of Clinical Investigation|March 22, 2022
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variantsChang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, et al.
Pageof 61